Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 18452568)

1.

Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.

Perry A, Miller CR, Gujrati M, Scheithauer BW, Zambrano SC, Jost SC, Raghavan R, Qian J, Cochran EJ, Huse JT, Holland EC, Burger PC, Rosenblum MK.

Brain Pathol. 2009 Jan;19(1):81-90. doi: 10.1111/j.1750-3639.2008.00167.x. Epub 2008 Apr 29.

PMID:
18452568
2.
3.

Supratentorial primitive neuroectodermal tumors of the central nervous system in adults: molecular and histopathologic analysis of 12 cases.

Gessi M, Setty P, Bisceglia M, zur Muehlen A, Lauriola L, Waha A, Giangaspero F, Pietsch T.

Am J Surg Pathol. 2011 Apr;35(4):573-82. doi: 10.1097/PAS.0b013e31820f1ce0.

PMID:
21378543
4.

Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.

Scheurlen WG, Schwabe GC, Joos S, Mollenhauer J, Sörensen N, Kühl J.

J Clin Oncol. 1998 Jul;16(7):2478-85.

PMID:
9667267
5.

Central nervous system primitive neuroectodermal tumors: a clinicopathologic and genetic study of 33 cases.

Behdad A, Perry A.

Brain Pathol. 2010 Mar;20(2):441-50. doi: 10.1111/j.1750-3639.2009.00314.x. Epub 2009 Jun 25.

PMID:
19725831
6.

MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.

Grotzer MA, Hogarty MD, Janss AJ, Liu X, Zhao H, Eggert A, Sutton LN, Rorke LB, Brodeur GM, Phillips PC.

Clin Cancer Res. 2001 Aug;7(8):2425-33.

7.

Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.

Jimenez RE, Folpe AL, Lapham RL, Ro JY, O'Shea PA, Weiss SW, Amin MB.

Am J Surg Pathol. 2002 Mar;26(3):320-7.

PMID:
11859203
8.

Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.

Bobola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM, Meade EH, Gross ME, Silber JR.

Clin Cancer Res. 2005 Oct 15;11(20):7405-14.

9.

Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.

Prados MD, Wara W, Edwards MS, Ater J, Rabbit J, Lamborn K, Davis R, Levin VA.

Pediatr Neurosurg. 1996 Oct;25(4):174-81.

PMID:
9293544
10.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

11.

Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.

Terterov S, Krieger MD, Bowen I, McComb JG.

J Neurosurg Pediatr. 2010 Aug;6(2):131-6. doi: 10.3171/2010.5.PEDS09333.

PMID:
20672933
12.

Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.

Frühwald MC, O'Dorisio MS, Rush LJ, Reiter JL, Smiraglia DJ, Wenger G, Costello JF, White PS, Krahe R, Brodeur GM, Plass C.

J Med Genet. 2000 Jul;37(7):501-9.

13.

Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.

Yasuda K, Taguchi H, Sawamura Y, Ikeda J, Aoyama H, Fujieda K, Ishii N, Kashiwamura M, Iwasaki Y, Shirato H.

Jpn J Clin Oncol. 2008 Jul;38(7):486-92. doi: 10.1093/jjco/hyn049. Epub 2008 Jun 23.

14.

Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.

Song X, Andrew Allen R, Terence Dunn S, Fung KM, Farmer P, Gandhi S, Ranjan T, Demopoulos A, Symons M, Schulder M, Li JY.

Int J Clin Exp Pathol. 2011;4(7):651-60. Epub 2011 Sep 17.

15.

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.

Nicholson HS, Kretschmar CS, Krailo M, Bernstein M, Kadota R, Fort D, Friedman H, Harris MB, Tedeschi-Blok N, Mazewski C, Sato J, Reaman GH.

Cancer. 2007 Oct 1;110(7):1542-50.

16.

Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.

Combs SE, Bischof M, Welzel T, Hof H, Oertel S, Debus J, Schulz-Ertner D.

J Neurooncol. 2008 Sep;89(2):205-10. doi: 10.1007/s11060-008-9607-4. Epub 2008 May 7.

PMID:
18461281
17.
18.

Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children.

Vassal G, Terrier-Lacombe MJ, Lellouch-Tubiana A, Valery CA, Sainte-Rose C, Morizet J, Ardouin P, Riou G, Kalifa C, Gouyette A.

Int J Cancer. 1996 Apr 22;69(2):146-51.

PMID:
8608984
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk